Annual Net Income:
-$121.24M-$77.17M(-175.06%)Summary
- As of today, MLTX annual net profit is -$121.24 million, with the most recent change of -$77.17 million (-175.06%) on December 31, 2024.
- During the last 3 years, MLTX annual net income has fallen by -$67.60 million (-126.02%).
- MLTX annual net income is now -133429.07% below its all-time high of -$90.80 thousand, reached on December 1, 2020.
Performance
MLTX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Net Income:
-$56.05M-$15.49M(-38.20%)Summary
- As of today, MLTX quarterly net profit is -$56.05 million, with the most recent change of -$15.49 million (-38.20%) on June 30, 2025.
- Over the past year, MLTX quarterly net income has dropped by -$31.29 million (-126.39%).
- MLTX quarterly net income is now -1120920.00% below its all-time high of -$5000.00, reached on September 1, 2020.
Performance
MLTX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Net Income:
-$179.12M-$31.29M(-21.17%)Summary
- As of today, MLTX TTM net profit is -$179.12 million, with the most recent change of -$31.29 million (-21.17%) on June 30, 2025.
- Over the past year, MLTX TTM net income has dropped by -$120.88 million (-207.55%).
- MLTX TTM net income is now -3582302.00% below its all-time high of -$5000.00, reached on September 1, 2020.
Performance
MLTX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
MLTX Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -175.1% | -126.4% | -207.6% |
| 3Y3 Years | -126.0% | -221.8% | -232.3% |
| 5Y5 Years | -10000.0% | -10000.0% | -10000.0% |
MLTX Net Income Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -175.1% | at low | -610.6% | at low | -306.4% | at low |
| 5Y | 5-Year | >-9999.0% | at low | >-9999.0% | at low | >-9999.0% | at low |
| All-Time | All-Time | >-9999.0% | at low | >-9999.0% | at low | >-9999.0% | at low |
MLTX Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$56.05M(-38.2%) | -$179.12M(-21.2%) |
| Mar 2025 | - | -$40.56M(+12.6%) | -$147.83M(-21.9%) |
| Dec 2024 | -$121.24M(-175.1%) | -$46.40M(-28.5%) | -$121.24M(-46.5%) |
| Sep 2024 | - | -$36.11M(-45.9%) | -$82.74M(-42.1%) |
| Jun 2024 | - | -$24.76M(-77.2%) | -$58.24M(-27.1%) |
| Mar 2024 | - | -$13.98M(-77.2%) | -$45.84M(-4.0%) |
| Dec 2023 | -$44.08M(+31.7%) | -$7.89M(+32.1%) | -$44.08M(+16.3%) |
| Sep 2023 | - | -$11.62M(+5.9%) | -$52.66M(+5.6%) |
| Jun 2023 | - | -$12.35M(-1.1%) | -$55.78M(+8.3%) |
| Mar 2023 | - | -$12.22M(+25.8%) | -$60.84M(+5.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$64.51M(-20.2%) | -$16.47M(-11.7%) | -$64.51M(-3.4%) |
| Sep 2022 | - | -$14.74M(+15.4%) | -$62.36M(-15.7%) |
| Jun 2022 | - | -$17.42M(-9.7%) | -$53.90M(+22.1%) |
| Mar 2022 | - | -$15.88M(-10.9%) | -$69.17M(-29.6%) |
| Dec 2021 | -$53.64M(>-9900.0%) | -$14.32M(-127.7%) | -$53.37M(-36.4%) |
| Sep 2021 | - | -$6.29M(+80.8%) | -$39.14M(-19.1%) |
| Jun 2021 | - | -$32.69M(>-9900.0%) | -$32.85M(>-9900.0%) |
| Mar 2021 | - | -$76.30K(+11.1%) | -$167.10K(-84.0%) |
| Dec 2020 | -$90.80K | -$85.80K(-1616.0%) | -$90.80K(-1716.0%) |
| Sep 2020 | - | -$5000.00 | -$5000.00 |
FAQ
- What is MoonLake Immunotherapeutics annual net profit?
- What is the all-time high annual net income for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual net income year-on-year change?
- What is MoonLake Immunotherapeutics quarterly net profit?
- What is the all-time high quarterly net income for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly net income year-on-year change?
- What is MoonLake Immunotherapeutics TTM net profit?
- What is the all-time high TTM net income for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics TTM net income year-on-year change?
What is MoonLake Immunotherapeutics annual net profit?
The current annual net income of MLTX is -$121.24M
What is the all-time high annual net income for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual net profit is -$90.80K
What is MoonLake Immunotherapeutics annual net income year-on-year change?
Over the past year, MLTX annual net profit has changed by -$77.17M (-175.06%)
What is MoonLake Immunotherapeutics quarterly net profit?
The current quarterly net income of MLTX is -$56.05M
What is the all-time high quarterly net income for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly net profit is -$5000.00
What is MoonLake Immunotherapeutics quarterly net income year-on-year change?
Over the past year, MLTX quarterly net profit has changed by -$31.29M (-126.39%)
What is MoonLake Immunotherapeutics TTM net profit?
The current TTM net income of MLTX is -$179.12M
What is the all-time high TTM net income for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high TTM net profit is -$5000.00
What is MoonLake Immunotherapeutics TTM net income year-on-year change?
Over the past year, MLTX TTM net profit has changed by -$120.88M (-207.55%)